We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
11501
PUT
Tvardi Therapeutics
TVRD
$22.1M
$186K ﹤0.01%
425
-483
-53% -$198K
POTX
11502
CALL
DELISTED
Global X Cannabis ETF
POTX
$186K ﹤0.01%
5,683
+3,400
+149% +$106K
CFRX
11503
CALL
DELISTED
ContraFect Corporation
CFRX
$186K ﹤0.01%
636
-1,578
-71% -$384K
DRTS icon
11504
Alpha Tau Medical
DRTS
$1.31B
$185K ﹤0.01%
+15,668
New +$184K
LPL icon
11505
CALL
LG Display
LPL
$3.37B
$185K ﹤0.01%
22,400
-11,200
-33% -$95.2K
RES icon
11506
CALL
RPC Inc
RES
$1.39B
$185K ﹤0.01%
17,300
+1,700
+11% +$13.6K
RWAY icon
11507
Runway Growth Finance
RWAY
$292M
$185K ﹤0.01%
13,601
-70,549
-84% -$934K
SCS
11508
PUT
DELISTED
Steelcase
SCS
$185K ﹤0.01%
15,500
-9,500
-38% -$115K
SJT
11509
CALL
San Juan Basin Royalty Trust
SJT
$129M
$185K ﹤0.01%
21,100
-7,200
-25% -$50.4K
VKTX icon
11510
PUT
Viking Therapeutics
VKTX
$3.84B
$185K ﹤0.01%
61,800
-17,700
-22% -$63.5K
KA
11511
CALL
DELISTED
Kineta, Inc. Common Stock
KA
$185K ﹤0.01%
+17,643
New +$217K
TTOO
11512
DELISTED
T2 Biosystems, Inc
TTOO
$185K ﹤0.01%
71
+13
+22% +$27.6K
ESSC
11513
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$185K ﹤0.01%
+17,862
New +$198K
NRXP icon
11514
PUT
NRX Pharmaceuticals
NRXP
$143M
$184K ﹤0.01%
7,500
-12,130
-62% -$395K
SST icon
11515
System1
SST
$17.8M
$184K ﹤0.01%
1,268
-418,402
-100% -$51.4M
WIMI
11516
WiMi Hologram Cloud
WIMI
$24.5M
$184K ﹤0.01%
6,881
-982
-12% -$26.4K
RKTA.WS
11517
DELISTED
Rocket Internet Growth Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RKTA.WS
$184K ﹤0.01%
481,198
-12,625
-3% -$6.54K
STRY
11518
DELISTED
Starry Group Holdings, Inc.
STRY
$184K ﹤0.01%
+22,237
New +$192K
QFTA.WS
11519
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$184K ﹤0.01%
625,000
APEN
11520
DELISTED
Apollo Endosurgery, Inc.
APEN
$183K ﹤0.01%
30,341
-43,076
-59% -$262K
AILEW
11521
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$183K ﹤0.01%
625,000
BTBT icon
11522
Bit Digital
BTBT
$520M
$182K ﹤0.01%
+50,459
New +$212K
ESPR
11523
DELISTED
Esperion Therapeutics
ESPR
$182K ﹤0.01%
39,318
-192,499
-83% -$826K
REKR icon
11524
Rekor Systems
REKR
$97.6M
$182K ﹤0.01%
+39,896
New +$188K
WT icon
11525
CALL
WisdomTree
WT
$3.44B
$182K ﹤0.01%
31,000
+9,000
+41% +$51.4K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.